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Abstract. Ciliary chondrodysplasias represent a heterogenous group of rare, nearly exclusively autosomal recessively inherited
developmental conditions. While the skeletal phenotype, mainly affecting limbs, ribs and sometimes the craniofacial skeleton, is
predominant, extraskeletal disease affecting the kidneys, liver, heart, eyes and other organs and tissues is observed inconsistently.
Significant lethality, resulting from cardiorespiratory failure due to thoracic constriction as well as from renal and hepatic
insufficiency or primary cardiac failure due to congenital heart disease, is observed with these conditions. The underlying
genetic defects as well as developmental biology and cell biology work undertaken using animal model systems, suggest
that these rare conditions result from ciliary malfunction. The skeletal phenotype is believed to result from imbalances in the
hedgehog signaling pathway that normally occurs in functional cilia in chondrocytes. Although phenotypes have been historically
distinguished based on clinical features into short-rib polydactyly syndrome, Jeune asphyxiating thoracic dystrophy, Mainzer-
Saldino syndrome, Sensenbrenner syndrome (cranioectodermal dysplasia), oral-facial-digital syndrome and Ellis-van Creveld
syndrome, recent research suggests that there is significant genetic as well as phenotypic overlap between the conditions. This
review discusses ciliary chondrodysplasias from phenotypic hallmarks to clinical management and summarizes progress in
identification of the underlying molecular mechanisms as well as potential future therapeutic perspectives.
Keywords: Cilia, chondrodysplasia, Jeune syndrome, short-rib polydactyly syndrome, Sensenbrenner syndrome
1. Introduction
The term “ciliary chondrodysplasias” summarizes
inherited conditions resulting from cilia malfunction
affecting skeletal development in mammals. Estimated
disease frequencies are 1 in 200,000 [1] to more than
1,000,000 in western populations [2], but can be higher
in genetically isolated populations [3]. However, as no
large patient studies have been performed, no exact
numbers are available.
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Cilia are hair-like organelles projecting from the
surface of cells and can be divided into two main
subgroups: motile cilia, occurring in bundles of hun-
dreds and single non-motile (primary) cilia. While the
presence of motile cilia is restricted to highly spe-
cialized tissues such as the respiratory tract, brain
ventricles, reproductive tract and embryonic node in
mammals, primary cilia can be found on nearly every
cell throughout the organism. Each cilium contains
nine pairs of microtubules (9 + 0 structure) and a 10th
pair, the so-called central pair, is additionally present
in motile cilia (9 + 2 structure). These motile cilia
also contain other proteins necessary for the motile
apparatus such as dynein arms and radial spokes not
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Fig. 1. Schematic of the ciliary ultrastructure. Primary cilia consist of nine pairs of microtubules, while motile cilia display an additional central
pair as shown in the cross-sections. The ciliary axoneme extends from the basal body, the former mother centriole of the cell, and is covered
by ciliary membrane. Transition zone fibers connect ciliary membrane with the cilium and are thought to form a barrier towards the cellular
cytoplasm. The ciliary pocket has been identified as a hub for cell signaling pathways and it is thought that proteins produced within the cell
body are transported to the ciliary pocket within vesicles.
observed in primary cilia. Figure 1 depicts a sim-
plified schematic of the ciliary ultrastructure. The
main function of motile cilia is fluid movement and
mucociliary clearance. Defects in genes encoding for
proteins of the motile apparatus lead to a cystic fibrosis-
like disease named primary ciliary dyskinesia (PCD;
MIM 244400). Roughly, half of individuals affected by
PCD present with laterality defects, which are due to
impaired motile ciliary function in the embryonic node
[4]. Laterality defects can also occur in non-motile
ciliopathies, usually in combination with many other
features. Over the past two decades, an increasing num-
ber of human genetic conditions have been linked to
malfunction of primary cilia, such as polycystic kidney
disease (MIM 173900, MIM 613095, MIM 236200),
nephronophthisis (NPHP; MIM 256100), Joubert syn-
drome (MIM 213300), Bardet-Biedl syndrome (MIM
209900), Alstro¨m syndrome (MIM 203800) and the
ciliary chondrodysplasias, which are highlighted in this
review [5].
Ciliary chondrodysplasias represent a group of
phenotypically and genetically related disorders inher-
ited in an autosomal recessive fashion including
short-rib polydactyly syndromes, which are also
referred to as short-rib thoracic dystrophy (SRPS;
MIM 611263, MIM 613091, MIM 263520, MIM
269860, MIM 614091), Jeune asphyxiating thoracic
dystrophy or Jeune syndrome (JATD; MIM 208500),
Mainzer-Saldino syndrome (MZSDS; MIM 266920),
Sensenbrenner syndrome or cranio-ectodermal dyspla-
sia (CED; MIM 218330), oral-facial-digital syndrome
4 (OFD4; MIM 258860) and Ellis-van Creveld syn-
drome (EVC; MIM 225500). An exception from this
inheritance pattern is Weyers acrodental dysostosis
(WAD; MIM 193530), which is caused by heterozy-
gous mutations in the EVC genes. Recently, ciliary
chondrodysplasias with narrow thorax and polydactyly
such as SRPS and JATD have also been summa-
rized under the term short-rib thoracic dystrophy
(SRTD). However, the current SRTD classification
in MIM takes only into account the underlying
genetic cause while the former SRPS and JATD clas-
sification was based on phenotypic features. This
can be confusing, therefore in this review I will
relate to the previous established clinical classifica-
tion of ciliary chondrodysplasias. Clinical hallmarks of
the ciliary chondrodysplasia group include shortened
limbs and ribs, polydactyly and sometimes craniofacial
M. Schmidts / Ciliary chondrodysplasias 51
malformations such as craniosynostosis. Renal, liver,
eye, heart and other organ involvement may be
additionally present and phenotype severity varies sig-
nificantly between the different conditions, but also
between patients with the same condition [6]. The
most severe thoracic constriction is usually seen in
SRPS and JATD. The thoracic phenotype in SRPS is
not compatible with life beyond the early neonatal age
due to cardiorespiratory failure, while approximately
40% of affected individuals with JATD survive into
adulthood after a period of intensive care and threat
of cardiopulmonary arrest during infancy [7]. In con-
trast to SRPS and JATD, individuals with MZSDS
and CED usually display a much milder rib pheno-
type, but frequently develop extraskeletal symptoms
such as childhood onset end-stage renal disease, liver
disease and retinal degeneration [8]. CED and EVC
further lead to additional ectodermal defects such as
dysplastic finger and toenails, hair and teeth abnor-
malities [9]. Finally, EVC is frequently associated with
congenital heart anomalies such as primary atrial sep-
tation defects [10, 11]. A complete overview of ciliary
chondrodysplasias is shown in Table 1.
In contrast to PCD where lack of ciliary motil-
ity leads to the impaired fluid movement, disease
mechanisms for non-motile ciliopathies are less well
understood. However, the skeletal phenotype includ-
ing polydactyly, observed in numerous ciliopathies in
humans and mice, gave an early clue that defective
hedgehog signaling might play a role. In this review,
the clinical features, progress in gene identification
over the last years, clinical management and future
prospects regarding ciliary chondrodysplasias will be
described.
2. Clinical features of ciliary chondrodysplasias
As briefly described above, extensive phenotypic
overlap is observed between different conditions of
the ciliary chondrodysplasias disease spectrum, so that
clinical diagnosis can be difficult to make, especially in
fetal cases. Radiographs of the skeleton play a crucial
role, but even for experts it may be difficult to dis-
tinguish between the different forms [12]. This might
appear arbitrary, however, making a precise diagno-
sis may help to predict the clinical course: SRPS are
always lethal [6], MZSDS and CED have a milder
rib phenotype but higher rate of renal, retinal and
liver disease than classical JATD [8, 13–15] while in
EVC, severe heart defects are most frequent [10, 16].
Nevertheless, knowing the underlying genetic defect
might represent a more suitable prediction tool for
disease severity and phenotypic features than apply-
ing a clinical disease term. Further, identification of
the causative gene improves opportunities for genetic
counseling.
2.1. Phenotypic spectrum of perinatal lethal SPRS
The phenotypic SRPS disease group consists of
SRPS I-V, but JATD could be considered as the mild
end of the spectrum: while polydactyly is a consis-
tent feature of SRPS, it is rarely observed in JATD
and the rib phenotype is usually milder in JATD
accounting for reduced lethality compared to SRPS.
Further, while extraskeletal malformations of the brain,
heart, kidneys, liver and pancreas can be frequently
observed in SRPS in prenatal ultrasound examinations,
this is usually not the case for JATD. Five subtypes
of SRPS are phenotypically distinguished: SRPS-I
(Saldino-Noonan type; MIM 613091 [17]; SRPS-II
(Majewski type; MIM 263520 [18], SRPS-III
(Verma-Naumoff type; MIM 613091 [19], SRPS-IV
(Beemer-Langer type; MIM 269860 [20] and SRPS-
V (MIM 614091 [21]). Typical clinical SRPS features
are displayed in Fig. 2.
2.1.1. SRPS-I and SRPS-III
Similar to SRPS-II and IV, polydactyly, hydropic
appearance and small thorax with short horizontal
ribs causing cardiorespiratory lethality, is observed in
SRPS-I. However, the typical hallmark of SRPS-I is
extreme micromelia resulting in ‘flipper-like’ limbs
[17]. Ossification defects of the vertebrae, pelvis, as
well as of the bones of the hands and feet are also
frequently observed. Pelvis anomalies include small
ilia with flattened acetabular roofs with ossified spurs,
resembling the pelvis configuration in EVC and JATD.
Polycystic kidneys, transposition of the great vessels
as well as atretic lesions of the gastrointestinal and
genitourinary systems are reported extraskeletal fea-
tures [22–24]. SRPS-III shares the typical features of
SRPS such as hydropic appearance at birth, short long
bones, short horizontal ribs, narrow thorax and protu-
berant abdomen, but is additionally characterized by a
short cranial base, bulging forehead, depressed nasal
bridge and flat occiput [19]. Radiologically, the long
tubular bones show a corticomedullary demarcation,
slightly widened metaphyses and marked longitudinal
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Fig. 2. Phenotypic features of short-rib thoracic dystrophy, oral-facial-digital syndrome 4 and Jeune asphyxiating thoracic dystrophy. Radio-
logical hallmarks of short-rib polydactyly syndrome (A) and oral-facial-digital syndrome 4 (B, C) including shortened long bones and short
horizontal ribs, small thorax, protruding abdomen and polydactyly. (D–I) Clinical features of Jeune asphyxiating thoracic dystrophy: narrow
thorax (D, G, H), horizontal short ribs and handlebar clavicles (D), acetabular spurs (F) and cone-shaped epiphyses of the phalanges (E).
Polydactyly is rarely observed (I). Reprinted with permission from El Hokayem et al. NEK1 and DYNC2H1 are both involved in short-rib
polydactyly syndrome. J Med Genet 2012;49(4):227-33. Copyright 2012 J Med Genet. (Picture A); Thomas et al. TCTN3 mutations cause
Mohr-Majewski syndrome. Am J Hum Genet 2012;91(2):372-8. Copyright 2012 Am J Hum Genet (pictures B and C); Halbritter et al. Defects
in the IFT-B component IFT172 cause Jeune and Mainzer Saldino syndromes in humans. Am J Hum Genet. 2013; 93(5):915-25. Copyright
2013 Am J Hum Genet. (pictures D, G and I); Schmidts et al. Combined NGS approaches identify mutations in the intraflagellar transport gene
IFT140 in skeletal ciliopathies with early progressive kidney disease. Hum Mut 2013; 34(5):7714-24. Copyright 2013 Hum Mut (picture E).
spurs. The structure of the pelvis in SRPS-III resembles
the pelvis configuration observed in SRPS-I, EVC
and JATD. Although commonly observed, polydactyly
is not completely penetrant. Cleft lip and palate are
reported as well as malformation of the larynx and
epiglottis [25, 26]. In contrast to SRPS-I, where devel-
opmental urogenital defects seem common, those are
rarely observed in SRPS-III [27].
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2.1.2. SRPS-II, SRPS-IV and OFD4
The clinical picture in SRPS-II and SRPS-IV is
quite similar with hydropic appearance at birth, short
long bones, small and narrow thorax with horizontal
ribs and protuberant abdomen [18], but in contrast
to SRPS-II, polydactyly is often absent in SRPS-IV.
Also, disproportional short tibia (the tibia is shorter
than the fibula), a hallmark of SRPS-II, is not observed
in SRPS-IV [23]. However, dysplastic tibia also occur
in OFD4 (Mohr-Majewski syndrome, Baraitser-Burn
syndrome; MIM 258860), presenting with variable
thoracic constriction, pre- and postaxial polydactyly
of hands and feet, cleft and pseudo-cleft of the lip
and/or palate, lobulated tongue, cystic dysplastic kid-
ney and liver involvement, brain malformations [28],
severe bilateral deafness [29] and coloboma of the eye
[30]. Orofacial clefts, cerebral malformations and renal
involvement are also observed in SRPS-II [23, 31], and
SRPS-IV [3, 20, 32, 33].
2.1.3. SRPS-V
SRPS-V was only recently described and the
underlying genetic defect identified in two consecu-
tively affected pregnancies of a mother from Maori
descent from New Zealand. Hydrops, narrow chest
and severely shortened and bowed long bones dis-
playing lack of ossification, hypoplastic scapulae, and
peritoneal calcifications, postaxial poly-syndactyly
and cleft palate were reported. Extraskeletal findings
include bilateral cystic hygroma, hypospadias, mainly
glomerular kidney cysts and intestinal malrotation.
Acromesomelic hypomineralization and campomelia
distinguish SRPS-V from SRPS subtypes I-III [21, 34].
2.2. Phenotypic spectrum of childhood
chondrodysplasias
There are a number of ciliary chondrodysplasias that
have significant overlap with the SRPS, but that are
less severe and occur in childhood and therefore have
been summarized with SRPS under the term SRTD.
These include JATD, MZSDS, CED, and EVC. WAD
in contrast does not affect the thorax.
2.2.1. JATD
JATD is characterized by a narrow, sometimes bell-
shaped thorax due to shortening of the ribs, which
restricts pulmonary development and may cause severe
respiratory distress during the first two years of life,
but compared to SRPS, the phenotype is less severe
(Fig. 2). Respiratory problems account for most of the
mortality in JATD ranging from 20–60% [1, 7, 35], but
patients seem to somewhat “grow out” of the respira-
tory phenotype [7, 35, 36]. Other skeletal hallmarks
include pelvis abnormalities similar to those observed
in SRPS-I, III and EVC, cone-shaped epiphyses and
infrequently polydactyly (Fig. 2). End-stage renal dis-
ease in childhood due to NPHP-like (and rarely cystic)
kidney involvement affects probably less than 20%
of all individuals with JATD, and seems to depend
mainly on the underlying genetic defect with muta-
tions in IFT140 and IFT172 predicting this phenotype
with nearly 100% probability [8, 13, 14]. Patients with
mutations in one of those two genes also develop retinal
degeneration, while this phenotype has been described
as “rare” in literature [37, 38]. However, Baujat et al.
[35] observed electroretinogram (ERG) abnormalities
in up to 50% of JATD patients with DYNC2H1 muta-
tions but it is not clear to date how many of these
patients will develop clinically relevant retinal dis-
ease later on. Pancreatic lesions [39], elevated liver
enzymes [13, 40] and brain malformations [13, 41, 42]
can also occur in JATD. The latter are rare in JATD,
but common in Joubert syndrome and can be imaged
as a so-called molar tooth sign on magnetic resonance
imaging.
2.2.2. MZSDS
Like JATD, MZSDS is described as “cono-renal
syndrome” due to cone-shaped epiphyses observed
radiologically after the first year of life (Fig. 3). This
phenotype occurs in association with impaired renal
function (due to both polycystic disease and NPHP)
and retinal degeneration. Similar as in JATD, the tho-
rax of MZSDS patients is often narrow but to a milder
degree [23, 43–45] (Fig. 3). JATD and MZSDS dis-
eases are considered allelic disorders [8, 13, 14]. Like
in JATD, age of onset and speed of progression for
renal and retinal disease vary between and even within
families and complicates accurate prognosis for these
patients. Additionally, the information that is cur-
rently available about retinal disease relies on different
tests (ERG, fundoscopy) that are not equally sensi-
tive, e.g. fundoscopy may appear normal in case of
retinal degeneration without pigmentary deposits and
although ERG is very informative, it is difficult to
obtain reliable ERG results in non-cooperative young
children. In summary, accurate conclusions cannot be
drawn at the moment but childhood onset for renal
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Fig. 3. Clinical hallmarks of Mainzer-Saldino syndrome and Sensenbrenner syndrome. Mildly narrowed thorax (A, B) and brachydactyly
with cone-shaped epiphyses of the phalanges (C) define the skeletal phenotype in Mainzer-Saldino syndrome. Reprinted with permission from
Perrault et al. Mainzer-Saldino Syndrome is a ciliopathy caused by IFT140 mutations. Am J Hum Genet 2012;90(5):864-70. Copyrgight 2012
Am J Hum Genet. (picture A); Schmidts et al. Combined NGS approaches identify mutations in the intraflagellar transport gene IFT140 in
skeletal ciliopathies with early progressive kidney disease. Hum Mut 2013; 34(5):7714-24. Copyright 2013 Hum Mut (picture c); reprinted
with permission from Walczak-Sztulpa et al. Cranioectodermal dysplasia, Sensenbrenner syndrome, is a ciliopathy caused by mutations in the
IFT122 gene. Am J Hum Genet 2010; 86(6):949-56. Copyright 2010 Am J Hum Mut and from Bedrup et al. Ciliopathies with skeletal anomalies
and renal insufficiency due to mutations in the IFT-A gene WDR19. J Med Genet 2011; 89(5); 634-43. Copyright 2011 J Med Genet.
and retinal disease seems common for patients with
IFT140 and IFT172 mutations [8, 13, 14]. Hepatic
involvement with cholestasis and fibrosis has also been
observed in some cases [8, 13]. Last, Mainzer et al. [43]
and Giedion [46] described some of their of MZSDS
patients with ataxia, a finding not confirmed in later
studies [8, 13].
2.2.3. Sensenbrenner syndrome
In contrast to JATD and MZSDS subjects, patients
with CED present characteristic facial dysmorphic fea-
tures and ectodermal defects including nail, hair and
teeth abnormalities (Fig. 3). Common skeletal features
are rhizomelic micromelia and brachydactyly as well
as variable narrowing of the thorax, which is usu-
ally milder than what is observed in JATD or SRPS
(Fig. 3) [9, 15]. However, dolichocephalus resulting
from craniosynostosis of the sutura sagittalis [47], can
be helpful to distinguish CED from other ciliopathies
[48]. In contrast to JATD and MZSDS, developmental
delay and skin laxity, potentially increasing the risk of
hernias, can be additional features. Visceral manifes-
tations frequently occur and often include progressive
renal failure due to a NPHP-like renal phenotype
with small hyperechogenic kidneys, the histological
picture of tubulointerstitial nephritis and microscopic
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Fig. 4. Schematic presentation of intraflagellar transport. Ciliary proteins are thought to be transported to the cilium within vesicles that merge
with the ciliary membrane in the ciliary pocket area. Anterograde intraflagellar transport (IFT) from the ciliary base to the tip is facilitated by
IFT complex B, while retrograde transport back the base requires IFT complex A. Most genes found to be involved in ciliary chondrodysplasias
encode for proteins of complex A and the associated motor complex, cytoplasmic dynein-2. However, EVC/EVC2, CSPP1 and NEK1 localize
to the base of the cilium and TCTN3 is found at the ciliary transition zone. To date, no human mutations have been identified in the motor
for complex B, kinesin-2. Hedgehog (Hh) signaling is essential to maintain a balance between proliferation and cellular differentiation at the
growth plates. In Hh signaling, activated GLI proteins finally translocate to the nucleus where they influence gene expression. IFT mutant mice
as well as mice lacking Evc function show abnormal hedgehog signaling, potentially due to disturbed localization of the hedgehog receptor
smoothened to the cilium.
glomerular and tubular cysts [49, 50]. Hepatic cysts,
fibrosis and ductal plate malformation are also com-
mon [51–53], while heart defects and retinal dystrophy
are less frequent [15].
2.2.4. EVC syndrome
EVC was first recognized in 1940 by Ellis and
van Creveld [54], and McKusick et al. [55] described
a large consanguineous Amish pedigree in Pennsyl-
vania in 1964. Acromelic dwarfism, polydactyly of
the hands (but not feet), ectodermal defects such
as dysplastic nails and teeth abnormalities (prenatal
eruption of teeth, hypodontia and malformed teeth)
and cardiac defects are classical hallmarks; EVC is
therefore referred to as “six finger dwarfism”. The
heart defects mainly represent primary atrial sep-
tal defects [11, 55] affecting approximately half of
all patients. Hydrocephalus due to a Dandy-Walker
malformation has also been described [56]. Radi-
ological features in EVC, including brachydactyly,
polydactyly, short ribs and trident acetabulum with
spurs, can make this condition difficult to distinguish
from JATD, however, cardiac and ectodermal defects
are common in EVC and not a feature of JATD,
while JATD patients may rather present with additional
renal, liver, and retinal disease not usually observed in
EVC [2].
2.2.5. Weyers acrodental dysostosis (WAD)
WAD or Curry-Hall syndrome was first described
by Weyers [57], and is allelic to EVC, however inher-
ited in an autosomal dominant pattern. Patients present
with a milder phenotype consisting of polydactyly of
the hands, dentition anomalies such as abnormal shape
and number of teeth, and dystrophic nails as well as
short stature with short extremities. In contrast to EVC,
thoracic constriction and/or visceral involvement is
usually not observed [57–60].
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3. Progress in gene identiﬁcation
Except WAD, ciliary chondrodysplasias are inher-
ited autosomal recessively. Genetic heterogeneity is
significant, especially for JATD and CED and genetic
overlap is observed between different SRPS types
as well as between SRPS, JATD, MZSDS and CED
(Fig. 4). Similar to other (genetically heterogeneous)
ciliopathies, ciliary chondrodysplasias have hugely
benefited from the introduction of next-generation
sequencing (NGS) which is currently revolutionising
patient genotyping and gene discovery in the research
setting in form of gene panel sequencing and whole
exome and genome sequencing. This has led to the
identification of many new human disease associated
genes over the last years, mostly encoding intraflag-
ellar transport (IFT) proteins (IFT172 [13], WDR19
[61], TTC21B [62], IFT140 [8, 14], IFT122 [52],
IFT80 [63, 64], IFT43 [65], and WDR35 [21, 66])
or components of the retrograde IFT motor complex
dynein-2 (i.e. DYNC2H1 [67–69], WDR34 [70–73],
and WDR60 [74, 75]). Further, proteins localizing
to the base of the cilium (basal body, peri-basal
body region or pericentriolar matrix) seem to play
a role as indicated by mutations in genes encoding
for NEK1 [69, 76], CSPP1 [42] and EVC/EVC2 [77,
78]. TCTN3, mutated in OFD4, localizes to the cil-
iary transition zone that forms a barrier between the
ciliary and cytoplasmic compartments [79]. The pro-
portion of cases caused by mutations in currently
known disease causing genes varies between the differ-
ent conditions: while the vast majority of EVC cases
occurs due to mutations in EVC and EVC2 [80] and
causative mutations in NEK1 and DYNC2H1 are found
in over 2/3 of all SRPS-II cases [69], the majority of
all MZSDS are caused by IFT140 and IFT172 muta-
tions [8, 13], and every other OFD4 case appears to
result from mutations in TCTN3 [79]. JATD is genet-
ically more heterogeneous. Most cases are caused
by mutations in DYNC2H1 (approximately 50%) [7,
35], followed by mutations in WDR34 (approximately
10%) [70, 71], and currently more than 70% of all
patients harboring mutations in known genes. Simi-
larly, multiple genes have been found to cause CED
and the frequency of WDR19, IFT122 and WDR35
mutations seems fairly equally distributed, whereas
mutations in IFT43 are less commonly identified. The
total number of cases reported to date is, however,
too small to draw final conclusions in this respect
[15].
First genotype-phenotype correlations especially in
JATD and MZSDS and the phenotypic spectrum of
CED further suggest that mutations in IFT complex A
components lead to a rather mild rib phenotype but
often cause significant extraskeletal symptoms such
as renal, hepatic and retinal disease [8,13–15], while
DYNC2H1 mutations are associated with a very severe
thorax phenotype but infrequent clinically relevant
renal or eye involvement in affected children [7, 35].
Digenic inheritance of heterozygous mutations in
two different genes has been reported in a single case
of SRPS-II with a heterozygous mutation in NEK1 as
well as DYNC2H1 [76]. So-called “triallelic inheri-
tance”, previously described in other ciliopathies such
as Bardet-Biedl syndrome [81] has not been described
in ciliary dysplasias to date. However, there are indi-
cations that “mutational load” (the total of mutations
in genes known to cause the disease), could potentially
play a role in ciliary chondrodysplasias [14].
4. Molecular mechanisms
Many genes implicated in ciliary chondrodysplasias
to date encode for proteins involved in IFT, mostly
components of the IFT complex A (retrograde trans-
port) [8, 14, 21, 52, 61, 62, 65, 66], but also two
components of IFT complex B (anterograde transport)
[13, 63] as well as the dynein-2 complex represent-
ing the motor for IFT-A [67, 68, 70, 71, 74]. EVC
and EVC2 are found at the ciliary base [82], but do
not seem to be involved in IFT, while NEK1 encodes
a serine/threonine kinase involved in the control of
cell-cycle dependent ciliogenesis [76]. CSPP1 also
localizes to the base of the cilium but its function
there has not been elucidated to date [42, 83, 84]. Last,
TCTN3 is found in a complex with TCTN1 and TCTN2
at the ciliary transition zone [79] (Fig. 4).
Because the cilium does not have a protein syn-
thesis machinery, all required proteins are produced
within the cell body and transported to the base of the
cilium where they are subsequently loaded onto IFT
particles, which facilitate transport along the ciliary
axoneme towards the ciliary tip (anterograde IFT, com-
plex B, powered by kinesin motor complexes). IFT is
also required to translocate molecules back towards the
base of the cilium (retrograde IFT, complex A, pow-
ered by the dynein-2 complex) [85–87]. Dysfunctional
IFT therefore leads to transport defects along the cil-
iary axoneme, causing ciliogenesis defects with absent
or very short cilia in extreme cases [4]. Mild forms of
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such defects have been described for patient’s fibrob-
lasts with mutations in DYNC2H1, NEK1, WDR19 and
WDR60 [61, 68, 74, 76]. However, in other patients
with mutations in genes encoding for retrograde IFT
proteins or the retrograde motor protein DYNC2H1,
cilia seem to be present on skin fibroblasts in normal
numbers and reach normal length, but accumulation of
IFT-B components at the ciliary tip can be observed
[7, 65]. While the Dync2h1 knockout mice display
a severe ciliogenesis defect [88], the milder cellular
human phenotype presumably results from hypomor-
phic missense mutations found in human patients [7].
Further, as expected, mutations in IFT172, impairing
anterograde transport, result in reduced incorporation
of ciliary proteins such as adenylate cyclase III and IFT
molecules into the ciliary axoneme [13].
As the cilium transmits signals from outside the cell
to the inside (serving as an “antenna”) and also pro-
cesses signals from within the cell [89–92], lack of
primary cilia or impaired IFT resulting in accumula-
tion or lack of signal transduction particles critically
interrupts the flow of cellular signaling information
causing severe developmental defects [93, 94]. Carti-
lage and bone development and growth is influenced
by many fundamental cell signaling pathways, but
the hedgehog signaling pathway has been identified
as crucially influencing chondrogenic (and subse-
quently osteogenic) proliferation and differentiation
[95]. Mouse models for Evc, Dync2h1 and Ift80 indi-
cate that IFT defects indeed lead to imbalances in the
hedgehog signaling pathway causing a premature stop
of chondrogenic proliferation and induction of chon-
drogenic differentiation at the growth plates severely
slowing down bone growth [82, 96]. IFT-A mouse
mutants seem to display ligand independent expan-
sion of hedgehog signaling resulting in abnormal digit
numbers and oro-facial clefts [88] (Fig. 4).
Renal and retinal disease are frequent ciliopathy
symptoms in ciliary chondrodysplasias [6] and seem
to mainly result from mutations in IFT-A genes [8, 14,
15] and the IFT-B component encoded by IFT172 [13],
while these traits are less frequently observed in sur-
viving patients with DYNC2H1 [7, 35] or IFT80 [63]
mutations. The underlying pathophysiological mecha-
nism remains to be defined. Cells in the kidney tubules
exhibit primary cilia, and loss of the physical structure
of the cilium as well as loss of ciliary proteins has been
shown to lead to renal cyst formation in mice [97–99].
While hypomorphic Ift80 knockout mice do not exhibit
any renal phenotype [96], loss of Ift140, or Ift172 in
mice produces an early onset kidney phenotype [100,
101], resembling human phenotype. Ift140 knockout
mice show normally orientated mitotic spindle axis,
but hyper-proliferation of renal tubular cells was noted
in the pre-cystic epithelium, while increased canoni-
cal Wnt and hedgehog signaling was only observed
in cystic tissue [100]. Unbalances between the canon-
ical and non-canonical Wnt pathways with loss of
non-canonical and increased canonical signaling have
been previously associated with dysfunction of genes
causing NPHP when disrupted. The best known exam-
ple concerns the INVS gene encoding inversin: loss of
function causes situs inversus and NPHP in humans
and mice, and inversin was shown to facilitate a switch
from canonical to noncanonical Wnt signaling in vivo
as well as in vitro, probably by targeting cytoplasmic
disheveled for ubiquitin-dependent degradation and
thereby reducing canonical Wnt signaling and promot-
ing non-canonical Wnt or planar cell polarity (PCP)
signaling [102, 103]. Neither disturbances in hedge-
hog nor Wnt signaling seem to initiate cyst formation
in Ift140 knockout mice but might contribute to cyst
progression. How this relates to the human pathophys-
iology remains to be defined.
Retinal photoreceptors consist of two parts cru-
cial for light processing: the inner and outer segment.
These segments are connected via a narrow bridge,
the so-called “connecting cilium” which shares simi-
larities with the transition zone of a classical cilium.
The connecting cilium is essential for (IFT-molecule
dependent) rhodopsin transport between the segments
and impaired transport results in accumulation of
rhodopsin causing photoreceptor death [72,104–106].
In contrast to the primarily developmental skeletal
phenotype resulting from IFT mutations, the retinal
phenotype therefore appears to be a degenerative pro-
cess. Like the renal phenotype, retinal degeneration
seems to be associated with mutations in IFT-A genes
and IFT172 [8,13–15], while it appears less common
in subjects with DYNC2H1 mutations [7, 35].
5. Clinical management and future perspectives
Ciliary chondrodysplasias are rare diseases and no
large long-term follow-up studies have been performed
to date. Curative therapies are not currently available
and treatment is therefore symptomatic. For SRPS sub-
types I–V, only short-term palliative care is possible
and therefore interruption of the pregnancy is usually
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recommended. OFD4, JATD, MZSDS, CED and EVC
patients in contrast require complex multidisciplinary
long-term clinical management approaches [2, 35, 36].
5.1. Skeleton
Lethality in ciliary chondrodysplasias is mainly
thought to be a result of cardiorespiratory failure due
to lung hypoplasia secondary to the constricted ribcage
(this does not occur in WAD). The majority of fatali-
ties occur in JATD and are observed perinatally and up
to the second birthday. Mechanical ventilation, contin-
uous positive airway pressure ventilation or oxygen
supply can be necessary for a long time. However,
as many patients seem to “grow out” of the thoracic
phenotype, invasive therapy is rarely required later in
life [2, 6, 7, 35, 36]. Thoracic expansion surgery may
be offered in cases where conservative treatment is
insufficient in a handful of highly specialized centers
worldwide, however, this treatment imposes a signifi-
cant risk [36, 107–111]. Pulmonary function should be
assessed by spirometry and volume measurements as
well as polygraphic sleep studies; these assays should
be performed every one to two years [35].
If ciliary chondrodysplasias cause secondary and/or
degenerative skeletal health issues later in life is not
clear to date due to lack of larger long-term follow-up
studies, but scoliosis appears to be a frequent feature in
JATD [7, 35]. While for subjects with EVC body length
ranges from 119 cm to 167 cm have been reported [2,
112, 113], many JATD patients reach normal adult
height [7, 35] with the exception of patients with
impaired renal function [14]. Growth hormone treat-
ment is currently not recommended for patients with
ciliary chondrodysplasias [2]. Extra fingers, neona-
tal teeth and craniosynostosis might require surgical
correction in the first 1–2 yr of life and additional
orthodontic corrections may be required later on.
5.2. Extraskeletal disease
Yearly monitoring of renal- and hepatic blood mark-
ers as well as ultrasound examination should be
performed, especially for patients with MZSDS and
CED as well as JATD individuals withWDR19, IFT140
or IFT172 mutations [8, 13–15]. JATD patients with
IFT80 and DYNC2H1 mutations seem at a lower risk
[7, 35, 63]. Supportive therapy includes dialysis and/or
renal/liver transplantation. The limited available data
suggests that most JATD and CED patients exhibit mild
liver disease [35, 36] with only a handful of cases
progressing into liver failure reported [13, 40, 114].
Elevated liver enzymes in JATD seem to respond to
ursodeoxycholic acid treatment [35, 115]. Liver dis-
ease is not associated with EVC and is infrequent in
MZSDS [2, 8, 13].
Patients with CED, MZSDS as well as JATD patients
with WDR19, IFT140 or IFT172 mutations are at sig-
nificant risk of developing retinal degeneration, mainly
with childhood onset [8, 13, 14]. As ERG changes
precede pathological findings in fundoscopy and clini-
cal manifestation of retinal dystrophy, eye monitoring
should always include ERG [116]. That said, it may
be difficult to obtain reliable ERG results in young
children. Clinically relevant sight loss seems to occur
less in young individuals with DYNC2H1 mutations
[7]. Nevertheless, these patients also require monitor-
ing as ERG abnormalities were noted in up to 50% of
cases [35]. Clinically relevant heart defects should be
treated according to cardiological guidelines, however,
heart defects can shorten life expectancy depending on
the defect and depending on if surgery is needed and
what kind of operation is required [2, 117]. Postoper-
ative mortality was reported as high as 44% in a small
Amish cohort with EVC [16].
Although most CED, JATD and MZSDS patients
develop normally, clinical and radiological features of
Joubert syndrome have been observed in a few JATD
and CED patients [41, 42] and some MZSDS patients
with ataxia [43, 46]. Evaluation by pediatric neurology
specialist should be undertaken for cases with neuro-
logical symptoms and/or developmental delay.
Therapy in ciliary chondrodysplasias is currently
symptomatic and supportive only. It will be challeng-
ing to attempt to therapeutically influence the skeletal
phenotype; first because one would have to start treat-
ment at birth or even in utero, and second because the
developing skeleton is not as easily accessible, e.g. the
respiratory tract, in case one would want to develop
gene therapy. The size of some of the genes involved
(e.g. DYNC2H1 and IFT172) represents an additional
hurdle. As most mutations are missense changes, read-
through drugs such as PTC124/ataluren will not be
applicable to many patients.
5.3. Psychological and genetic counseling
As ciliary chondrodysplasias have significant psy-
chological impact on affected families due to (often
late) interruptions of pregnancies, loss of children in
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the neonatal period or infancy, and chronic disease with
potential life threatening complications, psychological
counseling should be offered.
Genetic counseling is recommended for all ciliary
chondrodysplasias as the recurrence risk is 25% for
subsequent pregnancies, except for WAD with a risk
of 50%. Prenatal genetic testing should be offered to
families where the causative mutation is known and
families should be informed about the possibility of
pre-implantation diagnostics as well as sperm or egg
cell donation. That said, significant variability of the
phenotype severity is observed between patients from
different families with mutations in the same gene as
well as between siblings carrying the same mutations
[7, 74] can make it difficult to predict the exact phe-
notype for subsequent pregnancies based on genetic
findings.
In the past, extensive genetic- and phenotypical
heterogeneity as well as overlap between the differ-
ent disease entities have made it difficult to establish
a molecular diagnosis. However, the introduction of
NGS has significantly facilitated genetic diagnostics,
either in form of specific gene panels or whole-exome
sequencing. Single gene analysis still has a fairly high
success rate in EVC (EVC, EVC2), SRPS-II (NEK1),
OFD4 (TCTN3), and SRPS-V (WDR35), while in other
cases and for subjects where targeted sequencing of
the major causative gene does not reveal any muta-
tions, gene panel analysis seems more appropriate.
For instance, although the majority of all JATD cases
seem to be caused by mutations in DYNC2H1, due
to the large size of this gene, Sanger sequencing is
both relatively expensive and inefficient. Generally, if
no causative mutation can be identified using targeted
NGS panel approach, whole-exome and/or whole-
genome analysis might reveal the underlying genetic
defect. Copy number variant analysis of NGS data,
especially in exome- and whole-genome data, is highly
recommended [7].
In summary, ciliary chondrodysplasias require
multidisciplinary long-term clinical management
coordinated by the discipline most closely involved
with the patient. This can be best achieved in a centre
with experience with ciliary chondrodysplasias and all
disciplines located within this centre.
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